carbamazepine has been researched along with ursodeoxycholic acid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bonneton, J; Genton, P; Guitaoui, M; Mesdjian, E; Montet, AM; Montet, JC; Zamora, AJ | 1 |
| Aden, Y; Bertilsson, L; Bodin, K; Bretillon, L; Broomé, U; Diczfalusy, U; Einarsson, C | 1 |
| Jiang, A; LoGrasso, PV; Stearns, BA; Trauger, JW | 1 |
| Tan, B; Teng, P | 1 |
| Akyol, G; Callea, F; Dalgic, B; Francalanci, P; Giovannoni, I; Gonul, II; Sari, S; Yilmaz, G | 1 |
| Gong, JY; Knisely, AS; Wang, JS; Wang, NL; Zhang, MH | 1 |
2 review(s) available for carbamazepine and ursodeoxycholic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for carbamazepine and ursodeoxycholic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Ursodeoxycholate improves hepatobiliary dysfunction induced by valproate-carbamazepine treatment in the rat.
Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract; Carbamazepine; Liver; Male; Microscopy, Electron; Phospholipids; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid; Valproic Acid | 1996 |
Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.
Topics: Adult; Aged; Animals; Anticonvulsants; Carbamazepine; Cell Line; Cholagogues and Choleretics; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Humans; Hydroxycholesterols; Insecta; Kinetics; Male; Microsomes; Middle Aged; Mixed Function Oxygenases; Phenobarbital; Phenytoin; Recombinant Proteins; Ursodeoxycholic Acid | 2001 |
Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; 5-alpha-Dihydroprogesterone; Carbamazepine; Catalysis; Clozapine; Enzyme Activation; Enzyme Inhibitors; Fluoxetine; Flurbiprofen; Humans; Hydroxysteroid Dehydrogenases; Kinetics; Oxidation-Reduction; Pregnanediones; Pregnanolone; Recombinant Fusion Proteins; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Ursodeoxycholic Acid | 2002 |
Carbamazepine-induced DRESS syndrome in a child: rapid response to pulsed corticosteroids.
Topics: Adolescent; Anti-Inflammatory Agents; Anticonvulsants; Brain Injuries; Carbamazepine; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Emollients; Fluocinolone Acetonide; Hepatomegaly; Humans; Male; Methylprednisolone; Mineral Oil; Pulse Therapy, Drug; Seizures; Skin; Ursodeoxycholic Acid | 2013 |
Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child.
Topics: Afibrinogenemia; Carbamazepine; Child, Preschool; Cholagogues and Choleretics; Cytochrome P-450 CYP3A Inducers; Female; Fibrinogen; Humans; Hypobetalipoproteinemias; Liver; Liver Cirrhosis; Mutation, Missense; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Fibrinogen storage disease in a Chinese boy with de novo fibrinogen Aguadilla mutation: Incomplete response to carbamazepine and ursodeoxycholic acid.
Topics: Afibrinogenemia; Asian People; Carbamazepine; Child, Preschool; Fibrinogens, Abnormal; Genes, Dominant; Humans; Male; Mutation; Treatment Outcome; Ursodeoxycholic Acid | 2016 |